Torrent Pharmaceuticals Limited has announced that it has scheduled a teleconference with investors and analysts to discuss the company's financial performance for the quarter ended December 31, 2025. The conference call is scheduled for February 13, 2026, at 06:30 P.M. The company has provided universal dial-in numbers and international toll-free numbers for participation, along with a Diamond Pass Registration Link for easier access. This event allows stakeholders to gain insights into the company's financial results and future outlook.
